Vitamin C alleviates rheumatoid arthritis by modulating gut microbiota balance
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Vitamin C supplementation can help restore gut microbiota balance in rheumatoid arthritis (RA) models. This intervention alleviates arthritis symptoms by reducing key inflammatory markers, suggesting a potential therapeutic role for vitamin C in RA treatment.
Area Of Science
- Immunology
- Microbiology
- Gastroenterology
Background
- Rheumatoid arthritis (RA) is a systemic autoimmune disease with chronic inflammation.
- Gut microbiota imbalance is linked to RA progression, potentially via vitamin C degradation.
- The role of vitamin C in modulating the gut-joint axis in RA remains unclear.
Purpose Of The Study
- To evaluate vitamin C's effects on gut microbiota regulation in a rheumatoid arthritis mouse model.
- To elucidate vitamin C's potential role in the onset and progression of RA.
- To provide a basis for new RA intervention strategies and treatments.
Main Methods
- Collagen-induced arthritis (CIA) mouse models were utilized.
- Biochemical, histological, and 16S rRNA microbiological methods were employed.
- The study investigated the role and mechanism of vitamin C in rheumatoid arthritis.
Main Results
- Vitamin C treatment rescued gut microbiota imbalance in CIA mice.
- It suppressed RA-associated inflammatory responses.
- Arthritis symptoms were alleviated, with reduced levels of IL-6 and TNF-α.
Conclusions
- Vitamin C effectively regulates gut microbiota in an RA mouse model.
- It demonstrates potential as a therapeutic option for rheumatoid arthritis.
- Findings support vitamin C's role in managing the gut-joint axis in RA.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...